Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140378 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2023-02-16 | 2023-04-28 | 184943 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-19 | 2024-03-21 | 207551 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-25 | 2024-09-19 | 226177 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2025-05-15 | 2025-06-13 | 257541 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5226 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43171 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43174 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-10-11 | 2019-04-27 | 63757 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2019-08-22 | 2020-02-21 | 92183 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-08-22 | 2020-05-14 | 92186 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2019-08-22 | 2020-02-21 | 92189 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-09-19 | 2020-05-14 | 94381 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-03-24 | 2022-12-02 | 157256 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Actual shortage | 2024-02-09 | 2024-05-23 | 219038 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-05 | 224454 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-30 | 2021-04-01 | 127616 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |